Cardiometabolic risk factors in children and adolescents track into adulthood and are
associated with increased risk of atherosclerotic cardiovascular disease. The purpose of this …

Abstract Purpose of Review Familial hypercholesterolemia (FH), a common inherited
disorder of LDL-C metabolism that predisposes to premature cardiovascular disease, is …

Objectives To determine pediatricians' practices, attitudes, and barriers regarding screening
for and treatment of pediatric dyslipidemias in 9-to 11-year-olds and 17-to 21-year-olds …

BACKGROUND: Although low-density lipoprotein cholesterol (LDL-C) remains the primary
cholesterol target in clinical practice in children and adults, non–high-density lipoprotein …

Background Because atherosclerosis begins in childhood, universal lipid screening is
recommended with special attention to conditions predisposing to early atherosclerosis …

Objective To evaluate whether the release of national guidelines, electronic health record
(EHR) modifications, and educational initiatives correlated with changes in pediatricians' …

Universal lipid screening (ULS) is recommended for all 9-to 11-year-old children. We
investigated ULS outcomes and long-term pediatrician management of children with …

Background In 2011, a US expert panel recommended universal cholesterol screening for
children ages 9 to 11 years. Controversy exists over this recommendation, especially …

Background Early diagnosis and treatment of familial hypercholesterolemia reduces patient
morbidity and mortality associated with coronary heart disease. Despite guidelines …

Expert decisions often deviate from evidence-based guidelines. If experts are unaware of
guidelines, dissemination may improve outcomes. If experts are aware of guidelines but …